Revenue (Tables)

3 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

Summary of Disaggregation of Revenue Within Reportable Segment

The following table is a disaggregation of revenue within each reportable segment.

	Three Months Ended December 31,
(In thousands)	2023		2022
Medical Device
Product sales	$	11,950	$	8,380
Royalties & license fees – performance coatings		8,208		7,469
License fees – SurVeil DCB		971		1,296
Research, development and other		2,416		1,873
Medical Device Revenue		23,545		19,018
In Vitro Diagnostics
Product sales		6,877		5,854
Research, development and other		130		61
In Vitro Diagnostics Revenue		7,007		5,915
Total Revenue	$	30,552	$	24,933